TD
Translational Development Acquisition Corp.
TDACW · NASDAQ
$1.45 +346.15% (+$1.13)
1M -9.09%
Market Cap $38.2M
P/E Ratio 6.90x
Div. Yield -
ROE 3.28%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.26x
P/E 6.90x
EV/FFO N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
36 /100
Average ROA 3.52%
Asset turnover 0.00x
ROE 3.28%
Debt
0 /100
High Current ratio 0.06x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
0 /100
Unstable Beta 2.11x
EPS volatility N/A
Profitable years N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TDACW
Online
Sector
Financial Services
Industry
Shell Companies
CEO
Michael Hoffman
Employees
2
Headquarters
New York City